Home > Press > Lumera Corporation’s Dinu to Speak at the Lux Executive Summit
Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, today announced that Dr. Raluca Dinu, Vice President - Electro-Optic Business Unit, will present an overview of Lumera at the Lux Executive Summit being held in Boston on October 15.
Lumera Corporation’s Dinu to Speak at the Lux Executive Summit
BOTHELL, WA | Posted on October 2nd, 2007
The Lux Executive Summit brings together corporations, startups, and academic researchers working on commercializing cutting-edge technologies in fields including nanotech and cleantech. For more information on the conference, visit http://www.luxexecutivesummit.com/Overview/Overview.php .
About Lumera Corporation
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the communications/computing industries and for the bioscience industry through its wholly-owned subsidiary, Plexera Bioscience LLC. Both of these represent large market opportunities. The company also has developed proprietary processes for fabricating such devices.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
For more information, please click here
Hélène F. Jaillet, 425-398-6546
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014
Oxford Instruments launches 3rd annual Indian nanotechnology seminars in Kolkata and Delhi - sharing expertise with Nanotechnology researchers in India September 25th, 2014
Grenoble Hosting SEMICON Europa Oct. 7-9, First Time Event Held in France: Leti’s 90-square-meter Booth Will Feature Portable Showroom To Demonstrate New Technology Innovations September 24th, 2014
Contributing to the spirit of the IYCR 2014 September 24th, 2014
BSA Distinguished Lecture Tuesday, 10/14: 'LCLS: A Stunning New View Through X-ray Laser Eyes' September 23rd, 2014